Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
- PMID: 10817926
- DOI: 10.1016/s0736-5748(00)00012-5
Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology
Abstract
beta-Amyloid plaque deposition observed in brains from Alzheimer patients, might function as immune stimulus for glial/macrophages activation, which is supported by observations of activated microglia expressing interleukin (IL)-1beta and elevated IL-6 immunoreactivity in close proximity to amyloid plaques. To elucidate the mechanisms involved in beta-amyloid-mediated inflammation, transgenic mice (Tg2576) expressing high levels of the Swedish double mutation of human amyloid precursor protein and progressively developing typical beta-amyloid plaques in cortical brain regions including gliosis and astrocytosis, were examined for the expression pattern of a number of cytokines. Using ribonuclease protection assay, interleukin (IL)-1alpha,-beta, IL-1 receptor antagonist, IL-6, IL-10, IL-12, IL-18, interferon-gamma, and macrophage migration inhibitory factor (MIF) mRNA were not induced in a number of cortical areas of Tg2576 mice regardless of the postnatal ages studied ranging between 2 and 13 months. Using immunocytochemistry for IL-1alpha,beta, IL-6, tumor necrosis factor (TNF)-alpha, and macrophage chemotactic protein (MCP)-1, only IL-1beta was found to be induced in reactive astrocytes surrounding beta-amyloid deposits detected in 14-month-old Tg2576 mice. Using non-radioactive in situ hybridization glial fibrillary acidic protein (GFAP) mRNA was detected to be expressed by reactive astrocytes in close proximity to beta-amyloid plaques. The local immune response detected around cortical beta-amyloid deposits in transgenic Tg2576 mouse brain is seemingly different to that observed in brains from Alzheimer patients but may represent an initial event of chronic neuroinflammation at later stages of the disease.
Similar articles
-
Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.Brain Res. 2001 Mar 9;894(1):21-30. doi: 10.1016/s0006-8993(00)03176-0. Brain Res. 2001. PMID: 11245811
-
Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology.J Neurochem. 2003 Jul;86(2):283-9. doi: 10.1046/j.1471-4159.2003.01837.x. J Neurochem. 2003. PMID: 12871569
-
Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice.J Neuroimmunol. 2002 May;126(1-2):50-7. doi: 10.1016/s0165-5728(02)00050-4. J Neuroimmunol. 2002. PMID: 12020956
-
Glial cell dysregulation: a new perspective on Alzheimer disease.Neurotox Res. 2007 Dec;12(4):215-32. doi: 10.1007/BF03033906. Neurotox Res. 2007. PMID: 18201950 Review.
-
Metallothionein and brain inflammation.J Biol Inorg Chem. 2011 Oct;16(7):1103-13. doi: 10.1007/s00775-011-0802-y. Epub 2011 Jun 16. J Biol Inorg Chem. 2011. PMID: 21678079 Review.
Cited by
-
Early intervention with a small molecule inhibitor for tumor necrosis factor-α prevents cognitive deficits in a triple transgenic mouse model of Alzheimer's disease.J Neuroinflammation. 2012 May 25;9:99. doi: 10.1186/1742-2094-9-99. J Neuroinflammation. 2012. PMID: 22632257 Free PMC article.
-
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses.Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608. Aging Dis. 2024. PMID: 37450931 Free PMC article. Review.
-
New insights into clinical trial for Colostrinin in Alzheimer's disease.J Nutr Health Aging. 2009 Mar;13(3):235-41. doi: 10.1007/s12603-009-0065-2. J Nutr Health Aging. 2009. PMID: 19262960 Clinical Trial.
-
Loss of astrocytic domain organization in the epileptic brain.J Neurosci. 2008 Mar 26;28(13):3264-76. doi: 10.1523/JNEUROSCI.4980-07.2008. J Neurosci. 2008. PMID: 18367594 Free PMC article.
-
Employing new cellular therapeutic targets for Alzheimer's disease: a change for the better?Curr Neurovasc Res. 2005 Jan;2(1):55-72. doi: 10.2174/1567202052773508. Curr Neurovasc Res. 2005. PMID: 16181100 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous